WEPA NEDERLAND B.V. v. Essity Hygiene and Health Aktiebolag, UPC, CFI, CD Paris, 18 November 2026, Case no. UPC-CFI-0001898/2025
The Paris CD dismissed a revocation action brought by the Claimant against EP 3 289 139 B1, which related to a type of tissue paper comprising pulp fibers originating from Miscanthus and a method for manufacturing the product.
Numerous grounds of invalidity were relied upon, including novelty, obviousness, added matter and insufficiency. The CD applied the established case law of the UPC CoA.
One particular point of interest is that the Claimant sought to rely on experimental evidence contained in a document called WR17.
WR17 was submitted by Claimant in its Reply and its stated objective was: “To objectively evaluate the technical assertions made in EP 3 289 139 B1 regarding the alleged increase in tensile strength whilst maintaining softness”.
The report provided a two-phase investigation: controlled laboratory handsheet testing and industrial-scale trial tissue machine production trials. However, the CD agreed with the Defendant’s submissions, in particular that the disclosure of WR17 was insufficient to enable the experiments to be reproduced and verified. The CD concluded that WR17 had to be disregarded for lack of probative value.
A copy of the Decision can be found here.